Efficacy of an mHealth App to Support Patients’ Self-Management of Hypertension: Randomized Controlled Trial
Journal of Medical Internet Research · 19.12.2023 · 25 · e43809
DOI: 10.2196/43809 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Medical Internet Research, online erschienen am 19.12.2023. Verfasst von Fang Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Health Management Center, General Hospital of Ningxia Medical University, Yinchuan, China. Hauptthemen laut MEDLINE: Mobile Applications, Self-Management, Hypertension, Telemedicine. Die Arbeit wurde bisher 73-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Hypertension is a significant global disease burden. Mobile health (mHealth) offers a promising means to provide patients with hypertension with easy access to health care services. Yet, its efficacy needs to be validated, especially in lower-income areas with a high-salt diet.
Objective
This study aims to assess the efficacy of an mHealth app–based intervention in supporting patients’ self-management of hypertension.
Methods
A 2-arm randomized controlled trial was conducted among 297 patients with hypertension at the General Hospital of Ningxia Medical University, Ningxia Hui Autonomous Region, China. Participants selected via convenience sampling were randomly allocated into intervention and control groups. Intervention group participants were trained and asked to use an mHealth app named Blood Pressure Assistant for 6 months. They could use the app to record and upload vital signs, access educational materials, and receive self-management reminders and feedback from health care providers based on the analysis of the uploaded data. Control group participants received usual care. Blood pressure (BP) and 2 questionnaire surveys about hypertension knowledge and lifestyle behavior were used to assess all participants at baseline and 6 months. Data analysis was performed with SPSS software using 2-tailed t tests and a chi-square test.
Results
There were no significant differences in baseline characteristics and medication use between the 2 groups (all P>.05). After 6 months, although both groups show a significant pre-post improvement (P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health Management Center, General Hospital of Ningxia Medical University, Yinchuan, China.
- Department of Cardiology, General Hospital of Ningxia Medical University, Yinchuan, China.
- Centre for Digital Transformation, School of Computing and Information Technology, Faculty of Engineering and Information Sciences, University of Wollongong, Wollongong, Australia.
- The Ministry of Education Key Laboratory of Biomedical Engineering, College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou, China.
- Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, China.
- Shanghai Institute Of Cardiovascular Diseases, Shanghai, China.
ORCID-Profile: Fang Liu, Ting Song, Ping Yu, Ning Deng, Yingping Guan, Yang Yang, Yuanji Ma
Zitieren
APA
Liu, F., Song, T., Yu, P., Deng, N., Guan, Y., Yang, Y., & Ma, Y. (2023). Efficacy of an mHealth App to Support Patients’ Self-Management of Hypertension: Randomized Controlled Trial. Journal of Medical Internet Research, 25, e43809. https://doi.org/10.2196/43809
Vancouver
Liu F, Song T, Yu P, Deng N, Guan Y, Yang Y, et al. Efficacy of an mHealth App to Support Patients’ Self-Management of Hypertension: Randomized Controlled Trial. Journal of Medical Internet Research. 2023;25:e43809. doi:10.2196/43809
BibTeX
@article{Liu2023,
author = {Liu, Fang and Song, Ting and Yu, Ping and Deng, Ning and Guan, Yingping and Yang, Yang and Ma, Yuanji},
title = {Efficacy of an mHealth App to Support Patients’ Self-Management of Hypertension: Randomized Controlled Trial},
journal = {Journal of Medical Internet Research},
year = {2023},
volume = {25},
pages = {e43809},
doi = {10.2196/43809}
}
EUVIMED